Paperpal Prime Logo

Oncogene : Impact Factor & More

eISSN: 1476-5594pISSN: 0950-9232

Key Metrics

CiteScore
15.6
Impact Factor
5 - 10
Scite Index
0.94 5-Year SI
SNIP
1.79
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Oncogene

Oncogene Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGERNATURE
Language English
Frequency Weekly
General Details
LanguageEnglish
FrequencyWeekly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Oncogene ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Oncogene

IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer.
  • 7 Aug 2026
  • Oncogene
RAF1 S257L/S259F hotspot mutations: functional characterization and intrinsic resistance to the RAS(ON) inhibitor daraxonrasib in melanoma.
  • 7 Aug 2026
  • Oncogene
A comprehensive spatial proteome landscape of ectopic lymphoid-like structures in metastatic colorectal cancer reveals specific signatures for predicting clinical outcomes.
  • 7 Aug 2026
  • Oncogene
FGD5 regulates PGK1 ubiquitination to synergize with 2-deoxy-D-glucose in pancreatic ductal adenocarcinoma.
  • 7 Aug 2026
  • Oncogene
AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies.
  • 6 Aug 2026
  • Oncogene
TET2-driven demethylation of ANG promotes angiogenesis and malignant transformation in oligodendroglioma.
  • 5 Aug 2026
  • Oncogene
IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer.
  • 7 Aug 2026
  • Oncogene
RAF1 S257L/S259F hotspot mutations: functional characterization and intrinsic resistance to the RAS(ON) inhibitor daraxonrasib in melanoma.
  • 7 Aug 2026
  • Oncogene
A comprehensive spatial proteome landscape of ectopic lymphoid-like structures in metastatic colorectal cancer reveals specific signatures for predicting clinical outcomes.
  • 7 Aug 2026
  • Oncogene
FGD5 regulates PGK1 ubiquitination to synergize with 2-deoxy-D-glucose in pancreatic ductal adenocarcinoma.
  • 7 Aug 2026
  • Oncogene
AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies.
  • 6 Aug 2026
  • Oncogene
TET2-driven demethylation of ANG promotes angiogenesis and malignant transformation in oligodendroglioma.
  • 5 Aug 2026
  • Oncogene

FAQs on Oncogene